ETErdal Tekin

Erdal Tekin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erdal Tekin has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Professional Quality of Life among Emergency Healthcare Workers in Erzurum: Rural and Urban Differences

    by Ömer Faruk İşLeyen, Fatma Tortum, Erdal Tekin

    Aim:The professional quality of life for emergency department (ED) and emergency medical services (EMS) workers is affected by many factors. Environmental and operational differences between rural and urban settings may further influence these outcomes. This study aimed to compare the professional quality of life among emergency healthcare workers employed in rural and urban areas.Methods: This cross-sectional study was conducted between November 2025 and May 2026 in Erzurum, Türkiye. Physicians, nurses, and EMS personnel working in EDs and EMS stations were invited to participate. Professional quality of life was assessed using the Professional Quality of Life Scale Version 5 (ProQOL-5). Sociodemographic and occupational characteristics were also collected and compared between rural and urban healthcare workers.Results: A total of 203 healthcare professionals were included in the study, of whom 178 (87.7%) worked in rural areas and 25 (12.3%) in urban areas. Urban participants were significantly older and had greater professional seniority than rural participants (p

  • Open Access

    Demographic and Clinical Spectrum of Forensic Cases in the Emergency Department: A Retrospective Analysis of 25 887 Presentations

    by Fatma Tortum, Erdal Tekin, Ahmet Nezih Kök

    Background: This study aims to evaluate the demographic and temporal characteristics of forensic presentations involving physical or psychological harm, negligence, or intentional injury and to analyze the specific factors influencing mortality among these presentations. Methods: This single-center, retrospective, cross-sectional study was conducted on forensic presentations presenting to the emergency department. Demographic data, injury mechanisms, seasonal variations, and clinical outcomes were evaluated. Data retrieved from the hospital’s electronic health record system were analyzed statistically. Multivariable logistic regression analysis was performed to identify independent predictors of mortality. Results: A total of 25887 presentations were included in the study. Of the participants, 79.8% were adults and 68.9% were male, with a mean age of 34.0 ± 18.8 years. Motor vehicle accidents (21.0%) and falls from height (17.2%) were the most common injury mechanisms. Forensic presentations peaked in August (11.1%). While discharge rates were significantly higher in adults (61.9% vs. 41.3%; P < .001), mortality was significantly higher in pediatrics (2.1% vs. 1.2%; P < .001). Multivariable regression analysis identified firearm injuries (adjusted odds ratio = 7.12) as the mechanism most strongly associated with mortality in the adjusted model of mortality. Conclusion: Forensic presentations to the emergency department showed a significant concentration among young adult males and during the summer months. Although motor vehicle accidents and falls from height were the most frequent etiologies, multivariable analysis identified firearm injuries as the mechanism most strongly associated with mortality in the adjusted model of mortality. These findings suggest that the findings may help inform triage and resource-planning studies for high-risk injury mechanisms and pediatric populations. Furthermore, healthcare facilities should implement strategic resource and personnel planning to account for the seasonal surges in forensic presentations. Cite this article as: Tortum F, Tekin E, Kök AN. Demographic and clinical spectrum of forensic cases in the emergency department: a retrospective analysis of 25 887 patients. Eurasian J Med. 2026, 58(4), 1626, doi: 10.5152/eurasianjmed.2026.261626.

  • Open Access

    The Role of Endocan Level in Determining Large and Small Vessel Occlusion in Acute Ischemic Stroke

    by Erdal Tekin, Muhammet Çelik, Fatma Tortum, Ali Gür, İbRahim Özlü, Mehmet Nuri Koçak, Özcan AğyürEk, Mustafa Bayraktar

    Background: Stroke is a clinical condition in which blood flow to a brain area is interrupted by occlusion or hemorrhage. At present, the diagnosis and treatment of stroke are based on the use of biochemical markers and imaging methods. The degree of inflammation in the vessel wall may be reflected by changes in endocan levels. The aim of this study was the investigation of the role of endocan blood levels in the determination of large- and small-vessel occlusion in acute ischemic stroke. Methods: This was a prospective, single-center clinical study. Sociodemographic characteristics, physical examination, laboratory findings, and endocan levels were recorded. Patients with ischemic stroke were categorized as large-vessel occlusive (LVO) or small-vessel occlusive (SVO) on computed tomography (CT) angiography. Blood endocan levels were compared between the 2 groups. Results: A total of 110 patients were included in the study; the mean age of these patients was 69.2 years and 50.5% were male. Large-vessel occlusive was present in 33.3% (n = 31) of these patients, and endocan levels were higher in the LVO group but without statistical significance (P > .05). Modified Rankin Score was higher in the LVO group while Glasgow Coma Score was lower and both were statistically significant (P < .001). The area under the receiver-operating characteristic (ROC) curve for troponin was 0.762 and statistically significant (P = .001). Conclusion: Serum endocan levels did not differ significantly between LVO patients and controls. However, more research is needed to determine how significant these high endocan levels are in diagnosing major artery disease. Cite this article as: Tekin E, Çelik M, Tortum F, et al. The role of endocan level in determining large and small vessel occlusion in acute ischemic stroke. Eurasian J Med. 2026, 58(2), 1094, doi: 10.5152/ eurasianjmed.2026.251094.

  • Open Access

    The predictive value of the SMART-COP score in the management of acute pulmonary embolism in the emergency department

    by Fatma Tortum, Erdal Tekin, Bugra Kerget, Alperen Aksakal, Ozcan Agyurek

    Introduction: The current study evaluates how well the SMART-COP score predicts the necessity for hospitalization in patients diagnosed with acute pulmonary embolism (APE) within the emergency department (ED). Methods: A prospective study was conducted between July 10, 2023, and March 10, 2024, in the ED of a tertiary care hospital and included 105 patients diagnosed with APE. The echocardiographic findings along with the clinical outcomes of the patients in the ED (hospitalization or discharge) were correlated with the SMART-COP score. Statistical analyses were conducted utilizing SPSS version 25 (IBM Corp., Armonk, NY). To assess the predictive power of the SMART-COP score in determining the need for hospitalization, receiver operating characteristic (ROC) analysis was undertaken. Results: The study found that patients requiring hospitalization had higher SMART-COP scores, which were positively associated with right ventricular (RV) dysfunction and elevated pulmonary artery pressure (PAP). The SMART-COP score demonstrated a cut-off value of 2.50, with sensitivity and specificity values of 85.1% and 71.1%, respectively. Conclusion: The findings suggest that the SMART-COP score may serve as a valuable tool for assessing the need for hospitalization in patients with APE within the ED setting. This study highlights the importance of the SMART-COP score in the management of APE, particularly along with hemodynamic instability criteria. Also, this paper introduces the clinical application of SMART-COP score in rapid and efficient evaluations in emergency care.

  • Open Access

    Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients

    by Muhammet Celik, Erdal Tekin, Mehmet Nuri Koçak, Sevgi Karabulut Uzunçakmak, Mustafa Bayraktar

    Gremlin-1 is associated with lung disease and plays a role in the initiation and progression of pulmonary fibrosis. This suggests that Gremlin-1 may be associated with lung involvement in COVID-19 and poor clinical outcomes and warrants further investigation. This prospective, cross-sectional, single-blind study was the first to investigate Gremlin-1 levels in COVID-19 patients and whether Gremlin-1 levels could be used to predict and guide clinical follow-up in outpatients and inpatients. In this context, serum Gremlin-1 levels were measured and compared in 2 groups of patients who were diagnosed as positive for COVID-19 by RT-PCR and were followed up as outpatients (n = 28) or required hospitalization (n = 30). The median Gremlin-1 values were statistically significantly different between outpatients and intensive care unit patients (0.367 ng/mL [IQR = 0.377], 1.858 ng/mL [IQR = 2.245], respectively) (P < .0001). The area under the ROC curve value to determine the discriminative power of Gremlin-1 was found to be 0.772 (95% CI: 0.672–0.871; P < .0001), and the cutoff value of Gremlin-1 to discriminate between outpatients and hospitalized patients was found to be 1.242 ng/mL with 66.7% sensitivity and 67.2% specificity. Serum Gremlin-1 level is an important biomarker that can be used as a clinical decision-making tool for COVID-19 positive patients.


  • Open Access

    Neuroprotective Efficacy of Lycopene in a Thioacetamide-Induced Model of Hepatic Encephalopathy: An Experimental Rat Study

    by Erdal Tekin, Mustafa Bayraktar, Mehmet Nuri Koçak, Ufuk Okkay, Cemil Bayram, Zekai Halici, Muhammet Çelik, Ahmet Kızıltunç

    Lycopene has known antioxidant, anti-inflammatory, anti-proliferative, and neuroprotective effects. This is the first study to evaluate the potential protective role of lycopene against hepatic encephalopathy. An experimental hepatic encephalopathy model was established by intraperitoneal administration of thioacetamide to rats. A total of 24 rats were randomized into four groups: healthy group, control group, low-dose (50 mg/kg) lycopene group, and high-dose (100 mg/kg) lycopene group. The locomotor activity test was measured on the first day of the study to determine baseline measurements and again at the end of the study to determine changes. Blood samples were collected, and liver, brain, and lungs were removed and weighed. Except for stereotypic movements (p>0.05), all other final locomotor activity tests were statistically significant (p0.05), but IL-6, IL-10 and IL-1ꞵ analysis results were significant between control and healthy and high-dose lycopene groups (p<0.05). AST, ALT, total bilirubin, direct bilirubin and ammonia parameters were significantly lower in the low-dose lycopene group compared to the control and high-dose lycopene groups (p<0.05). Lycopene administration had hepatoprotective and neuroprotective efficacy against HE, supported both in locomotor activity tests and at biochemical tests.


  • The ability of end-tidal carbon dioxide value to predict the risk of major cardiovascular events in patients with acute coronary syndrome

    by Nazım Onur Can, Senol Arslan, Erdal Tekin, Halil İbRahim Doru

    In this study, the capacity of End-tidal carbon dioxide (EtCO2) levels to predict the risk of major cardiovascular events (MACE) in patients diagnosed with acute coronary syndrome and the relationship between risk scoring systems (TIMI, GRACE, HEART) and EtCO2 values were examined. EtCO2 values of the patients in the study were measured with a capnography device. Each patient's MACE status was recorded. The results we found in our study are as follows: (i) EtCO2 values were significantly lower in the group with MACE (n = 45) than in the group without MACE (n = 288) (p < 0.05). (ii) According to ROC analysis, EtCO2 was effective in predicting one-month mortality (AUC = 0.81, p < 0.00). (iii) The optimal EtCO2 cut-off point was 30 mmHg. This threshold value provided both sensitivity and specificity for the risk of MACE. (IV) Significant associations were found between EtCO2 and GRACE, TIMI and HEART scoring systems. EtCO2 values were significantly higher in the low-risk groups. (V) EtCO2 was significantly different in all three risk scoring systems in the non-MACE group, but only with the GRACE score in the MACE group. This study demonstrated that EtCO2 is a valuable indicator for predicting the risk of MACE in patients with ACS.

  • Open Access

    The Comparative Efficacy of Intravenous Ibuprofen 400 mg and 800 mg in Acute Mechanical Low Back Pain: A Prospective, Randomized, Double-Blind Clinical Study

    by Safa Dönmez, Erdal Tekin, Ahmet Burak Erdem, Alp Şener, Miray Tümer, Mehmet Yılmaz, Nurullah İsHak Işık, İbRahim Ozlu

    Objective: This study aimed to compare the analgesic efficacy of intravenous (IV) ibuprofen at doses of 400 mg and 800 mg for acute mechanical low back pain. Methods: A Prospective, randomized, double-blind controlled clinical trial design was employed. Patients with moderate to severe acute low back pain were recruited from emergency departments. Ethical approval was obtained, and patients provided written consent. The study adhered to ethical guidelines and Good Clinical Practice principles. Results: Of the 144 patients, demographic characteristics were similar between groups. The 800 mg IV ibuprofen group demonstrated superior analgesic efficacy compared to the 400 mg group, with no significant adverse effects reported. Conclusion: The study concludes that the 800 mg IV dose of ibuprofen was more effective in providing analgesia control for patients with acute mechanical low back pain at all time intervals except for the 30th minute.